Guizhou Sanli Pharmaceutical Co.,Ltd reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 969.51 million compared to CNY 710.14 million a year ago. Revenue was CNY 969.51 million compared to CNY 710.14 million a year ago.

Net income was CNY 157.97 million compared to CNY 103.64 million a year ago. Basic earnings per share from continuing operations was CNY 0.39 compared to CNY 0.25 a year ago. Diluted earnings per share from continuing operations was CNY 0.39 compared to CNY 0.25 a year ago.